MALIGNANT HISTIOCYTOSIS

MALIGNANT HISTIOCYTOSIS was reported 31 times

MALIGNANT HISTIOCYTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-13 Antagonist [EPC] 1 0.0001
1 Vitamin D Analog [EPC] 1 0.0001
2 Antimycobacterial [EPC] 1 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Topoisomerase Inhibitor [EPC] 2 0.0000
5 Purine Antimetabolite [EPC] 2 0.0000
6 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
7 BCL-2 Inhibitor [EPC] 1 0.0000
8 Glycopeptide Antibacterial [EPC] 1 0.0000
9 Androgen Receptor Inhibitor [EPC] 1 0.0000
10 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
11 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
12 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
13 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
14 Alkylating Drug [EPC] 2 0.0000
15 Sulfonylurea [EPC] 1 0.0000
16 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
17 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
18 Leukocyte Growth Factor [EPC] 1 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
20 Vitamin D [EPC] 2 0.0000
21 Azole Antifungal [EPC] 1 0.0000
22 Vitamin B12 [EPC] 2 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 Corticosteroid [EPC] 7 0.0000
26 Interferon beta [EPC] 1 0.0000
27 Vitamin C [EPC] 2 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 Retinoid [EPC] 1 0.0000
30 Osmotic Laxative [EPC] 1 0.0000
31 beta-Adrenergic Blocker [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
35 Atypical Antipsychotic [EPC] 1 0.0000
36 Loop Diuretic [EPC] 1 0.0000
37 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
38 Kinase Inhibitor [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000